Screener
Anika Therapeutics ANIK Business Segments — Income Loss From Continuing Operations
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperations.
The source filing: Anika Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001171843-26-005012
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 18,290 | 18,543 | 42,775 | 37,508 |
| Income (loss) from operations | 2,954 | (4,180) | (2,534) | (8,464) |
| Interest and other income, net | 426 | 214 | 1,093 | 629 |
| Income (loss) before income taxes | 3,380 | (3,966) | (1,441) | (7,835) |
| Provision for income taxes | 71 | 681 | 306 | 770 |
| Income (loss) from continuing operations | 3,309 | (4,647) | (1,747) | (8,605) |
| Income (loss) from discontinued operations, net of tax | - | 677 | - | (238) |
| Net income (loss) | $3,309 | $(3,970) | $(1,747) | $(8,843) |
ITEM 1. FINANCIAL STATEMENTS[ Item 1. Condensed Consolidated Financial Statements (unaudited): ](#)
FAQ
- What is Anika Therapeutics's business segments — income loss from continuing operations?
- Anika Therapeutics (ANIK) reported business segments — income loss from continuing operations of $3.31M in Q2 2026.
- What does business segments — income loss from continuing operations mean?
- This metric represents the net profit or loss generated by the company's core business activities, excluding any results from discontinued operations. It serves as a key indicator of the ongoing operational profitability and financial health of the primary orthopedic business segments. Investors use this to assess the sustainable earnings power of the company's core product portfolio.
Ask your AI about Anika Therapeutics's business segments — income loss from continuing operations.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude